In addition to the known complement activation pathways such as the classical, lectin, and alternative pathways, C3 can also be cleaved into C3a by the enzymatic activity of cathepsins which are upregulated in pancreatic cancer (37, 38). The gene discussed is C3; the disease is pancreatic neoplasm.